Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient diagnosed with tinea corporis clinically, as well as by KOH mount test without nail and scalp involvement. 2. BSA less then or equal to 20 percent. 3. Patient who are willing and able to provide informed consent.
Exclusion criteria
Exclusion criteria: 1. Presence of complications such as secondary bacterial infection of the lesions. 2. Patients already on topical and/or systemic antifungal treatment (1 week of topical therapy and/or 4 weeks of systemic antifungal therapy before baseline visit) 3. Patients with diabetes mellitus. 4. Immunosuppressant patients like AIDS/HIV infection. 4. Pregnant and lactating women. 5. Noncompliance with the trial protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Change in Investigator s global assessment(IGA)of clinical responses (see annexure-II for details) 2. Mycological cure: Clinically suspected cases of tinea corporis will be confirmed by skin scraping and KOH preparation, by visualizing presence or absence of long, narrow, septate and branching hyphae under microscope at baseline and at the conclusion of trial. Timepoint: 14th, 28th and 42nd day. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in TCS (Total clinical score) (see Annexure-III for details) 2. Changes in Dermatology Life Quality Index (see Annexure-IV for details) Timepoint: 14th, 28th and 42nd day. | — |
Countries
India